| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Research Abstract |
We assessed the effect of forced expression of miR-365, which was highly expressed in invasive pancreatic cancer compared with IPMN. miR-365 increased the cell viability of pancreatic cancer cells after the gemcitabine treatment, suggesting the induction of resistance. A comprehensive analysis of gene expression profiles in miR-365 introduced cells identified up-regulation of several NF kappa B target genes. Activation of NF kappa B pathway was confirmed by the increased expression of phosphorylated NF kappa B. On the other hand, miR-365 directly targeted apoptosis-related molecules such as SHC1 and BAX that led to the gemcitabine resistance.
|
